Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ImmProDynamics

Financiado

Cerrado

Dissecting the interplay between the dynamics of immune responses and pathogen p...

Dissecting the interplay between the dynamics of immune responses and pathogen proliferation in vivo Pathogen proliferation has profound implications for its persistence, treatment strategies, and the induction and execution of protective immune responses. In vivo, pathogen proliferation rates are heterogenic, confronting the imm... ver más

28/02/2022

OVGU

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

OTTOVONGUERICKEUNIVERSITAET MAGDEBURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-02-28

ERC-2016-STG: ERC Starting Grant

I+D

Cerrada hace 9 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

OVGU

1.50M€ | Lider

ZOOGESTION SL EN LIQUIDACION

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

BAXERNA 2.0 Immunopeptidomics-based Development of Next-Generation Bacte... 9M€ Cerrado

IMMUNITY TO LISTERIA Mechanisms of innate immune activation of the intracellular... 100K€ Cerrado

Immune Regulation How Infection History Shapes the Immune System Pathogen ind... 1M€ Cerrado

INBIONET Infection biology training network shaping the future of in... 4M€ Cerrado

MIBEst Molecular Infection Biology Estonia Research capacity buil... 797K€ Cerrado

ILTIS Innate Like T Cells In Sepsis ILTIS Implications for Earl... 98K€ Cerrado

Duración del proyecto: 62 meses Fecha Inicio: 2016-12-02
Fecha Fin: 2022-02-28

Líder del proyecto

OTTOVONGUERICKEUNIVERSITAET MAGDEBURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Pathogen proliferation has profound implications for its persistence, treatment strategies, and the induction and execution of protective immune responses. In vivo, pathogen proliferation rates are heterogenic, confronting the immune system with a variety of microbial physiological states. It is unknown if, and by what molecular mechanism, the immune response can distinguish these different states on a cellular level. Also, understanding the link between pathogen proliferation and immune cell dynamics could provide critical information on how infections can be controlled, and how to counteract pathogen persistence and antibiotic resistance. However, this question has never been addressed due to difficulties in studying the dynamics of immune cells and at the same time probing pathogen proliferation. In this project, we will make use of a novel in vivo reporter system that I have developed, in order to determine the role of the pathogen's proliferation for its interaction with the immune system. Specifically, we will (1) determine the tissue niche in which the pathogen proliferates, (2) investigate the differential dynamics of phagocyte-pathogen- and of T cell-APC-interactions related to pathogen proliferation rate, (3) manipulate the relationship between pathogen proliferation and immune cell dynamics by using proliferation-deficient mutants and optogenetic pathogen inactivation, (4) identify signaling pathways that are differentially induced in cells infected by high versus low proliferating pathogens, and test their involvement in differential immune cell dynamics related to pathogen proliferation. ImmProDynamics will for the first time provide insights into how cells of the immune system react to distinct pathogen proliferative states in vivo. This will greatly expand our knowledge of host-pathogen interactions, which will be critical for the design of efficient vaccines and antimicrobial therapy.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores